Progress in the Treatment of Non-small Cell Lung Cancer with BRAF Inhibitors

Progress in the Treatment of Non-small Cell Lung Cancer with BRAF Inhibitors

Blog Article

In recent years, targeted drugs occupy a pivotal position in the treatment beer button down shirts for men of non-small cell lung cancer (NSCLC), drugs targeting epidermal growth factor receptor (EGFR) has been widely used in clinical practice, it is of milestone significance.V-raf murine sarcoma viral oncogene homolog B1 (BRAF) inhibitors targeted at BRAF gene have obviously clinical efficacy to specific advantages populations with little side-effect, and be well tolerated.It is discovered recently that drug resistance also exists in BRAF inhibitors like other targeted drugs, the mechanism of drug resistance whole wheat phyllo dough is being studied.In this paper, a review were performed in the mechanism, clinical application, adverse reactions and the drug resistance of BRAF inhibitors.